You have 9 free searches left this month | for more free features.

City

Seoul (1)

Condition

Fibrosis (1)

Hematologic Malignancy (1)

Metastatic Pancreatic Adenocarcinoma (1)

Solid Tumor (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

CG Pharmaceuticals, Inc (1)

Machaon Biotherapeutics, Inc. (1)

Collaborator

Intervention

ivaltinostat (2)

capecitabine (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

ivaltinostat

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

Not yet recruiting

Hematologic Malignancy
+2 more

Ivaltinostat
Placebo

Seoul, Korea, Republic of

Seoul National University Hospital

Feb 6, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting

Metastatic Pancreatic Adenocarcinoma

Ivaltinostat
Capecitabine

(no location specified)

Feb 10, 2022